8-K: QT Imaging Holdings to be Delisted from Nasdaq After Failing to Meet Listing Requirements

QT Imaging Holdings will be delisted from the Nasdaq Stock Market and will begin trading on the over-the-counter market after failing to meet minimum market value and share price requirements.

Summary

• QT Imaging Holdings has received notice that its common stock will be delisted from the Nasdaq Stock Market.
• The delisting is due to the company's failure to maintain a minimum market value of listed securities (MVLS) of $50 million and a minimum share price of $1.00.
• The company was initially notified of non-compliance with the MVLS requirement on May 10, 2024, and the price rule on June 17, 2024.
• QT Imaging was given until December 16, 2024, to regain compliance with the price rule, but failed to do so.
• An appeal to a Nasdaq Hearings Panel was denied on January 24, 2025.
• Trading on Nasdaq was suspended effective January 28, 2025, and the stock will now trade on the over-the-counter market under the ticker symbol QTIH.
• The company intends to apply for listing on the OTCQX or OTCQB market tiers and may seek to relist on Nasdaq in the future if it meets the initial listing standards.

Sentiment

Score: 2

Explanation: The document details a significant negative event for the company, namely its delisting from Nasdaq, which is likely to negatively impact investor confidence and future prospects.

Positives

• The company intends to apply for listing on the OTCQX or OTCQB market tiers, providing a continued trading venue for its stock.
• QT Imaging may seek to relist on Nasdaq in the future if it meets the initial listing standards.

Negatives

• The company failed to maintain the minimum market value of listed securities of $50 million required for continued listing on Nasdaq.
• The company's share price remained below $1.00 for an extended period, violating Nasdaq's price rule.
• The company's appeal to the Nasdaq Hearings Panel was denied, leading to the delisting.
• The delisting from Nasdaq could negatively impact investor confidence and the company's ability to raise capital.

Risks

• The delisting from Nasdaq could negatively impact investor confidence and the company's ability to raise capital.
• There is no guarantee that the company will be able to successfully list on the OTCQX or OTCQB market tiers.
• The company's ability to relist on Nasdaq in the future is dependent on meeting the initial listing standards, which is not guaranteed.
• The company faces risks related to its debt obligations, market acceptance of its services, and general economic conditions.

Future Outlook

The company intends to apply to have its common stock listed on either the OTC Markets OTCQX or OTCQB market tier and may seek to relist on Nasdaq in the future if it meets the initial listing standards. The company does not expect the delisting to impact its day-to-day operations.

Management Comments

• The Company does not expect the Panels determination to have any impact on its day-to-day operations.
• The Company intends to apply to have its Companys common stock listed on either the OTC Markets OTCQX or OTCQB market tier, and if in the future, it is able to qualify to list on Nasdaq under the Nasdaqs initial listing standards, the Company intends to apply for listing on Nasdaq.

Industry Context

Delisting from a major exchange like Nasdaq can be a significant setback for a company, often leading to decreased investor confidence and potentially impacting future fundraising efforts. This situation highlights the importance of maintaining compliance with listing requirements and the challenges faced by companies that fail to do so. Other companies in similar situations may face similar challenges.

Comparison to Industry Standards

• Many companies that fail to meet Nasdaq's minimum listing requirements face delisting, which is a common occurrence.
• Companies like Sorrento Therapeutics and Faraday Future have also faced delisting from Nasdaq due to similar issues with market capitalization and share price.
• The move to the over-the-counter market is a typical step for companies that have been delisted from major exchanges.
• The intention to relist on Nasdaq is a common goal for companies that have been delisted, but it requires significant improvements in financial performance and market valuation.

Stakeholder Impact

• Shareholders will be impacted by the delisting from Nasdaq and the move to the over-the-counter market.
• The delisting may affect the company's ability to raise capital in the future.
• Employees may experience uncertainty due to the company's financial challenges.

Next Steps

• The company will begin trading on the over-the-counter market under the ticker symbol QTIH.
• The company intends to apply for listing on the OTCQX or OTCQB market tiers.
• The company may seek to relist on Nasdaq in the future if it meets the initial listing standards.

Key Dates

Keywords

delisting, Nasdaq, over-the-counter, market value, share price, listing requirements, OTCQX, OTCQB, QTIH, appeal